Genetic Characterization of Cancer of Unknown Primary Using Liquid Biopsy Approaches.

Of note, the frequency of ARID1A mutation decreases at time point B, during FOLFOX-4 treatment, then it increases during the progression of the disease, while the FGFR2 amplification has a decreasing trend in terms of copy number value during disease progression.

also in 47,180 other papers